PT95902A - Processo para a preparacao de derivados de piridazina uteis como ligandos dos receptores colinergicos - Google Patents
Processo para a preparacao de derivados de piridazina uteis como ligandos dos receptores colinergicosInfo
- Publication number
- PT95902A PT95902A PT95902A PT9590290A PT95902A PT 95902 A PT95902 A PT 95902A PT 95902 A PT95902 A PT 95902A PT 9590290 A PT9590290 A PT 9590290A PT 95902 A PT95902 A PT 95902A
- Authority
- PT
- Portugal
- Prior art keywords
- lygands
- uteric
- colinergic
- receptors
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8915137A FR2654727B1 (fr) | 1989-11-17 | 1989-11-17 | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
FR909007533A FR2663326B2 (fr) | 1989-11-17 | 1990-06-15 | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
Publications (2)
Publication Number | Publication Date |
---|---|
PT95902A true PT95902A (pt) | 1991-09-13 |
PT95902B PT95902B (pt) | 1998-01-30 |
Family
ID=26227673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95902A PT95902B (pt) | 1989-11-17 | 1990-11-15 | Processo para a preparacao de derivados de piridazina uteis como ligandos dos receptores colinergicos |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0429344B1 (pt) |
JP (1) | JPH03170465A (pt) |
KR (1) | KR0164599B1 (pt) |
AR (1) | AR247557A1 (pt) |
AT (1) | ATE143010T1 (pt) |
AU (1) | AU639043B2 (pt) |
CA (1) | CA2030133A1 (pt) |
DE (1) | DE69028602T2 (pt) |
DK (1) | DK0429344T3 (pt) |
ES (1) | ES2094146T3 (pt) |
FI (1) | FI101881B (pt) |
FR (1) | FR2663326B2 (pt) |
GR (1) | GR3021933T3 (pt) |
HK (1) | HK1000597A1 (pt) |
HU (2) | HU207852B (pt) |
IE (1) | IE75697B1 (pt) |
IL (1) | IL96384A (pt) |
LV (1) | LV11972B (pt) |
NO (1) | NO178967C (pt) |
NZ (1) | NZ236107A (pt) |
PT (1) | PT95902B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2665442B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
FR2676444B1 (fr) * | 1991-05-16 | 1995-03-10 | Sanofi Elf | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. |
KR100443893B1 (ko) * | 1996-01-15 | 2004-10-15 | 얀센 파마슈티카 엔.브이. | 혈관형성억제제피리다진아민 |
WO1999032448A1 (en) * | 1997-12-19 | 1999-07-01 | Amgen Inc. | Substituted pyridine and pyridazine compounds and their pharmaceutical use |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
CA2442004A1 (en) | 2001-03-23 | 2002-10-03 | David J. Kyle | Microbial feeds for aquaculture and agriculture |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
RU2416609C2 (ru) | 2005-12-07 | 2011-04-20 | Сумитомо Кемикал Компани, Лимитед | Соединение пиридазина и его применение |
FR2904314A1 (fr) * | 2006-07-26 | 2008-02-01 | Centre Nat Rech Scient | Composes pyridaziniques et pyrroliques lineaires, procedes d'obtention et applications |
AR081626A1 (es) * | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
EP2560488B1 (en) | 2010-04-23 | 2015-10-28 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
AR119731A1 (es) | 2019-05-17 | 2022-01-05 | Novartis Ag | Inhibidores del inflamasoma nlrp3 |
US20230107277A1 (en) * | 2020-03-27 | 2023-04-06 | Astellas Pharma Inc. | Substituted pyridazine compound |
EP4289823A4 (en) * | 2021-02-08 | 2025-02-26 | Medshine Discovery Inc | SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2510998B1 (fr) * | 1981-08-07 | 1986-01-10 | Sanofi Sa | Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent |
FR2540113A1 (fr) * | 1983-01-27 | 1984-08-03 | Sanofi Sa | Acides derives de la pyridazine actifs sur le systeme nerveux central |
DE3629929A1 (de) * | 1986-09-03 | 1988-03-10 | Thomae Gmbh Dr K | Neue sulfonamido-aethylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
FR2642648B1 (fr) * | 1989-02-07 | 1991-06-21 | Sanofi Sa | Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique |
PT93060B (pt) * | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
-
1990
- 1990-06-15 FR FR909007533A patent/FR2663326B2/fr not_active Expired - Lifetime
- 1990-11-15 PT PT95902A patent/PT95902B/pt not_active IP Right Cessation
- 1990-11-15 FI FI905663A patent/FI101881B/fi not_active IP Right Cessation
- 1990-11-16 ES ES90403239T patent/ES2094146T3/es not_active Expired - Lifetime
- 1990-11-16 DE DE69028602T patent/DE69028602T2/de not_active Expired - Fee Related
- 1990-11-16 NZ NZ236107A patent/NZ236107A/en unknown
- 1990-11-16 IE IE414590A patent/IE75697B1/en not_active IP Right Cessation
- 1990-11-16 JP JP2312597A patent/JPH03170465A/ja active Pending
- 1990-11-16 AU AU66672/90A patent/AU639043B2/en not_active Ceased
- 1990-11-16 NO NO904984A patent/NO178967C/no unknown
- 1990-11-16 HU HU907178A patent/HU207852B/hu not_active IP Right Cessation
- 1990-11-16 DK DK90403239.8T patent/DK0429344T3/da active
- 1990-11-16 EP EP90403239A patent/EP0429344B1/fr not_active Expired - Lifetime
- 1990-11-16 AT AT90403239T patent/ATE143010T1/de not_active IP Right Cessation
- 1990-11-16 CA CA002030133A patent/CA2030133A1/en active Granted
- 1990-11-16 AR AR90318401A patent/AR247557A1/es active
- 1990-11-17 KR KR1019900018663A patent/KR0164599B1/ko not_active IP Right Cessation
- 1990-11-18 IL IL9638490A patent/IL96384A/en not_active IP Right Cessation
-
1995
- 1995-06-27 HU HU95P/P00450P patent/HU211351A9/hu unknown
-
1996
- 1996-12-06 GR GR960403344T patent/GR3021933T3/el unknown
-
1997
- 1997-09-10 LV LVP-97-165A patent/LV11972B/lv unknown
- 1997-11-10 HK HK97102147A patent/HK1000597A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT93785A (pt) | Processo para a preparacao de derivados de 3-substituido-2-oxindole | |
PT93516A (pt) | Processo para a preparacao de derivados de2-anilino-pirimidina uteis para controlar pragas | |
PT90119A (pt) | Processo para a preparacao de um adocante | |
PT83389B (pt) | Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais | |
PT91188A (pt) | Processo para a preparacao de derivados de furano | |
PT84561B (pt) | Processo aperfeicoado para a preparacao de derivados macrolidos | |
PT94045A (pt) | Processo para a preparacao de derivados de 2-piperidino-1-alcanol uteis como agentes anti-isquemicos | |
PT89205A (pt) | Processo para a preparacao de derivados de indano | |
PT95902A (pt) | Processo para a preparacao de derivados de piridazina uteis como ligandos dos receptores colinergicos | |
PT91895A (pt) | Processo para a preparacao de 9h-purinas substituidas | |
PT92786A (pt) | Processo para a preparacao de compostos de tiazol | |
PT89922A (pt) | Processo para a preparacao de derivados da tiazolidenodiona | |
PT90914A (pt) | Processo para a preparacao de derivados de benzazepinae benzotiazapina | |
PT89545A (pt) | Processo para a preparacao de derivados da isoquinolinona | |
BR8702112A (pt) | Processo para a preparacao de um derivado de pirazol pirimidina | |
PT93629A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina | |
PT88181A (pt) | Processo para a preparacao de derivados aralquilaminoalcoxifenilo | |
BR9001503A (pt) | Processo para a preparacao de alquil-halogenossilanos | |
PT92365A (pt) | Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida | |
PT89775A (pt) | Processo para a preparacao de derivados de isoquinolina | |
PT91027A (pt) | Processo para a preparacao de derivados peptidicos | |
PT92539A (pt) | Processo para a preparacao de derivados de anfotericina b | |
PT94008A (pt) | Processo para a preparacao de novos derivados de tieno-triazolo-diazepina | |
PT93033A (pt) | Processo para a preparacao de derivados de guanidina | |
PT92808A (pt) | Processo para a preparacao de novos derivados de tetralina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19910405 |
|
FG3A | Patent granted, date of granting |
Effective date: 19971008 |
|
TE3A | Change of address (patent) | ||
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20000430 |